Search

everythinglearnresearchcommunity

for

Search:↓

Hormone therapy with estradiol and spironolactone can regrow scalp hair in transgender women by lowering testosterone to female levels.

Hair transplants can help transgender individuals match their appearance with their gender identity.

The inner root sheath is vital for hair follicle stability during growth changes.

The document recommends a multidisciplinary approach and experience sharing to advance facial feminization surgery as a medical field.

Transgender and gender diverse youth often have skin issues like acne and scarring, but few get referred to dermatologists.

Dermatologists are essential in helping transgender and gender diverse patients with skin and hair issues related to gender affirmation and hormone therapy.

Testosterone pellets might work for transgender men's hormone therapy, but more research is needed.

Bilateral Orchiectomy effectively reduces the need for anti-androgen medication in most transgender females.

Australia needs better dermatological guidelines for gender-diverse patients.

Australian doctors experienced in adult transgender healthcare mostly prescribe intramuscular testosterone and oral estradiol, recommend mental health assessments before hormone therapy, and support improved training and guidelines.

A transwoman developed a brain tumor after nine years of hormone therapy, suggesting a possible link between the treatment and tumor development.

Transgender and nonbinary individuals experience hair loss, with transmen on testosterone seeing more severe hair loss, while feminizing hormones may stabilize hair loss in transwomen.

Facial hair is crucial for transgender men's gender identity and transition.

Transgender men on testosterone therapy need ongoing gynecologic care due to potential cancer risks.

Forehead reduction and orbital contouring are important for satisfactory facial feminization in transgender females, with high satisfaction and low long-term problems.

Men and women have different hairline restoration needs, with natural design being more complex for women, and hairline changes being important for transgender individuals' transitions.

Telogen effluvium is a common, temporary hair loss condition often affecting young women.

Inclusive and culturally competent healthcare is crucial for transgender and non-binary individuals.

Animals that change color with the seasons mainly do so in response to daylight changes, but climate change is causing camouflage problems that may require evolutionary changes.

Following national healthy eating guidelines can help reduce risks from gender-affirming hormone therapy.

Hormone therapy affects hair growth in transgender individuals, with testosterone potentially causing hair loss in trans men and estrogen reducing facial/body hair in trans women; treatment options vary.

The document concludes that more inclusive research involving the transgender community is needed, especially on the neovaginal microbiome of trans women.

Accurate assessment of puberty using Tanner staging is crucial for identifying normal and abnormal development.

Most transgender patients getting laser hair removal before gender-affirming surgery are already on hormone therapy, which might affect the hair removal process.

Hair can naturally regain color, and stress might influence greying and its reversal.

A multidisciplinary approach is crucial for safe and effective hormone treatment in gender-dysphoric individuals, with specific guidelines for adolescents and adults.

The document concludes that treatments for hair loss in transgender and gender-diverse individuals include topical solutions, oral medications, laser therapy, and hair restoration procedures, with progress assessed after 6-12 months.

Transit-amplifying cells are crucial for tissue repair and can contribute to cancer when they malfunction.